FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054495 [Registered on: 27/06/2023] Trial Registered Prospectively
Last Modified On: 20/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Treatment of Benign Prostatic Hyperplasia using Kushaadi Taila Matra Basti (in the form of enema) and Gokshura Kwath ( to be taken freshly prepared orally by the patient)  
Scientific Title of Study   A Clinical study of Kushaadi Taila Matra Basti and Gokshura Kwath in Vatashtheela (Benign Prostatic Hyperplasia) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ajay Kumar Gupta 
Designation  Professor 
Affiliation  Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Address  OPD No-7, Department of Shalya Tantra, Rishikul Campus, Haridwar, Uttarakhand Ayurved University Haridwar Uttarakhand 249401 India

Hardwar
UTTARANCHAL
249401
India 
Phone  9412856414  
Fax    
Email  akg1409@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ajay Kumar Gupta 
Designation  Professor 
Affiliation  Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Address  OPD No-7, Department of Shalya Tantra, Rishikul Campus, Haridwar, Uttarakhand Ayurved University Haridwar Uttarakhand 249401 India

Hardwar
UTTARANCHAL
249401
India 
Phone  9412856414  
Fax    
Email  akg1409@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kajal Saini 
Designation  PG Scholar 
Affiliation  Rishikul Campus, Uttarakhand Ayurved University, Haridwar 
Address  OPD No-7, Department of Shalya Tantra, Rishikul Campus, Haridwar, Uttarakhand Ayurved University Haridwar Uttarakhand 249401 India

Hardwar
UTTARANCHAL
249401
India 
Phone  8171072006  
Fax    
Email  kajalsaini1227@gmail.com  
 
Source of Monetary or Material Support  
OPD No-7, Rishikul Campus, Haridwar 
 
Primary Sponsor  
Name  Uttarakhand Ayurved University 
Address  Uttarakhand Ayurved University, Railway Road, Harrawala, Dehradun 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kajal Saini  Rishikul Campus Haridwar  OPD No-7, Department of Shalya Tantra, Rishikul Campus Haridwar, Uttarakhand Ayurved University Uttarakhand 249401 India
Hardwar
UTTARANCHAL 
8171072006

kajalsaini1227@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Uttarakhand Ayurved University, Rishikul Campus, Haridwar   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N400||Benign prostatic hyperplasia without lower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gokshura Kwath, Reference: Bhaishjya Ratnavali/35/4, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 30(ml), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: Gokshura Kwath 30 ml daily orally (morning time)
2Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Bhavprakash/37/59-62, Procedure details: Kushaadi Taila Matra Basti 30 ml once daily per rectum in left lateral lying position (morning time))
(1) Medicine Name: Kushaadi Taila, Reference: Bhavprakash/37/59-62, Route: Rectal, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 21 Days
 
Inclusion Criteria  
Age From  50.00 Year(s)
Age To  99.00 Year(s)
Gender  Male 
Details  1.Patients with classical signs and symptoms of
Vatashtheela
2.Age group 50 years or above 50 years 
 
ExclusionCriteria 
Details  1.Age below 50 years
2.Patient with acute retention
3.Known malignant condition of Uro-genital system
4.Patient associated with other systemic disorder- Renal failure, Malignancy, immuno-compromised patients etc.
5.Patients not willing to undergo trial
6.Covid-19 non vaccinated patients
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in the symptoms like frequency of urination in day & night time urgency of urination & relief in signs such as enlargement of Prostate  7th 14th 21st day & after treatment 
 
Secondary Outcome  
Outcome  TimePoints 
Expected improvement in the quality of life of patients by relief in the symptoms like decrease in the number of Micturition by patient during day & night, Urgency, as well as expected relief in reduction of size of Prostate gland of Prostate  7th 14th 21st day & after treatment 
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
BPH is a non- cancerous disease and it is a part of normal ageing process. The most widely acknowledged cause is an imbalance between androgen and estrogen. It cause symptoms like increased frequency of micturition in day as well as night time, urgency, etc. and signs like enlargement in Prostate size.

This study is a interventional, open level, single group trial, A Clinical study of Kushaadi Taila Matra Basti and Gokshura Kwath in Vatashtheela (Benign Prostatic Hyperplasia). The case will be selected randomly from OPD/IPD of Rishikul Campus Hospital, U.A.U, Haridwar (U.K.) India. The study will be intervened under one group with Kushaadi Taila (Matra Basti) and Gokshura Kwath (orally), duration of trial will be 21 days. Assessment criteria will be done on subjective and objective parameters. Subjective parameters on the basis of International prostate symptom score (IPSS) and objective parameters on residual urine volume and prostate size volume. 
Close